SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Amgen, Inc.

Headquarters : One Amgen Center Drive Thousand Oaks, CA 91320 United States of America United States of America
Job offers, investor relations : web www.amgen.com tel. 805-447-1000 email: investor.relations@amgen.com stock : AMGN analytics

Brands

name
click to compare prices
Abgenix, Alantos Pharmaceuticals, Amgen, Aranesp
Denosumab
Enbrel, EPO, Epogen
G-CSF (Neupogen)
Ilypsa
Neulasta
Panitumumab
Tularik
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Amgen, Inc. , group and subsidiaries

Jobs -14% /1998 Fraud 1 Offshore 5 Sales 12 Bn $.€ /year Profit 7 Bn $.€ /1998 Wage 2931 *min. Influence 3
[click on the rating for the method or on the number for the data]
year
business
source
2006Amgen is the world's tenth-largest pharmaceutical group.Les Echos
2004Largest biotechnology group in the world.Les Echos
» More business descriptions and market shares for Amgen, Inc..
subsidiarycountry%source
Immunex United States of America100Les Echos
» More subsidiaries of Amgen, Inc.
country
address & contact : production type
incentive source
Barbados Barbados
Amgen Sales Corporation :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 8 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 7 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 6 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 5 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 4 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 3 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development 2 Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Clinical Development Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Bermuda Bermuda
Amgen (Bermuda) Manufacturing Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Hong-Kong Hong-Kong
Amgen Greater China Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
: usine, 1100 emplois
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Les Echos
Switzerland Switzerland
Amgen AG :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
» More locations of Amgen, Inc.
» The World map of tax haven, secret accounts and shell companies

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2006Morrow, Georges
See the photo of: Morrow, Georges Vice-president; salary: 2,69 million US$; stock-options: 6,92 million US$;
2005Danula, Richard D
See the photo of: Danula, Richard D Chief Financial Officer; salary: 1,98 million US$; stock-options: 3,46 million US$;
2005Sharer, Kevin W
See the photo of: Sharer, Kevin W Chief Executive Officer; salary: 5,89 million US$; stock-options: 27,87 million US$;
2000Baltimore, David
See the photo of: Baltimore, David Director;
2000Bowes, William K
See the photo of: Bowes, William K Director;
2000Choate, Jerry D
See the photo of: Choate, Jerry D Director;
2000Falberg, Kathryn E
See the photo of: Falberg, Kathryn E Chief Financial Officer;
2000Gluck, Frederick W
See the photo of: Gluck, Frederick W Director;
2000Johnson, Franklin P
See the photo of: Johnson, Franklin P Director;
2000Lazarus, Steven
See the photo of: Lazarus, Steven Director;
2000Omenn, Gilbert S
See the photo of: Omenn, Gilbert S Director;
2000Rice, Donald B
See the photo of: Rice, Donald B Director;
2000Sharer, Kevin W
See the photo of: Sharer, Kevin W Chief Executive Officer;
1998Binder, Gordon M
See the photo of: Binder, Gordon M Chief Executive Officer; salary: 10,54 million US$;
Forbes
» More executive salaries for Amgen, Inc.
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2007
-2600
Internal restructuring: Amgen is cutting 2600 jobs, 14% of its payroll, because lower sales of two blockbuster drugs.: United States of America
Les Echos
2005
16000
2004
14400
2003
12800
2002
10100
2001
7700
2000
7300
1998
5500
» More restructuring at Amgen, Inc.
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 8 informations, access to subscribers
» More restructuring at Amgen, Inc.
» Layoff plans and labour conditions in 2007

  • Subsidy

  • Advertising & marketing

yearfinancial misdemeanorsalesincome buybacksource
2006   5billion US$
2005   12,434,02   billion US$
2005   5billion US$Reuters
2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Canadian Press
2004   10,553,15   billion US$Enjeux Les Echos
2004   5billion US$
2003   8,36-2,54   billion US$
2002   5,52-1,66   billion US$
2001   4,021,12   billion US$
2000   3,631,14   billion US$
1999   3,341,1   billion US$
1999   2billion US$SmartMoney
1998   2,720,86   billion US$
1998   1billion US$SmartMoney
» More financial data for Amgen, Inc.
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 14 informations, access to subscribers
» More financial data for Amgen, Inc.
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
200915 American States, including the State of New York, bring suit against Amgen for corruption. Amgen, like ASD Healthcare and International Nephrology Network, are accused of having offered undue advantages to the health professionals to have them prescribe the Aranesp drug, used against anemia. This drug brought back 11 billion dollars to Amgen since its marketing in 2001. : translateAFP
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
1998Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 74 thousand US$ : US President, Congress, Senate translateCenter for Responsive Politics
» More influence from Amgen, Inc.
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 3 informations, access to subscribers
» More influence from Amgen, Inc.
» Influence in 2007
Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS